Search results
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo News· 1 month agoThis week, an FDA advisory committee unanimously recommended approval of Eli Lilly’s LLY Alzheimer's...
AstraZeneca CFO: 'We've come a long way in our oncology portfolio'
Yahoo Finance· 1 month agoAstraZeneca (AZN) has long been in the oncology and other disease spaces, but rose to popularity in...
Roche (RHHBY) Posts Encouraging Phase I Obesity Drug Data
Zacks via Yahoo News· 2 months agoData from the study shows that nearly half of the patients who received Roche's (RHHBY)...
Jacob Rees-Mogg claims UK government 'downplayed' risks of AstraZeneca COVID vaccine
Yahoo News UK· 2 months agoJacob Rees Mogg made the claims on his GB News show. (Getty) SOPA Images via Getty Images Jacob...
AstraZeneca withdraws its vaccine to protect against COVID-19 worldwide
CBC via Yahoo News· 2 months agoAstraZeneca says it is withdrawing Vaxzevria, its vaccine to protect against COVID-19, from global...
AstraZeneca withdraws its COVID-19 vaccine from global market
The Hill via Yahoo News· 2 months agoAstraZeneca is withdrawing its COVID-19 vaccine from the market because of low demand, the drugmaker...
Will withdrawal of AstraZeneca vaccine affect your next COVID booster jab?
Yahoo News UK· 2 months agoAstraZeneca is withdrawing its COVID vaccine, the company has announced. (PA) Jakub Porzycki,...
AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
The Independent via Yahoo News· 2 months agoAstraZeneca is withdrawing its Covid-19 vaccine worldwide, months after the pharma giant admitted...
AstraZeneca starts worldwide withdrawal of COVID vaccine
Sky News via Yahoo News· 2 months agoAstraZeneca has begun the worldwide withdrawal of its COVID vaccine - ending an era in which it...
AstraZeneca withdraws Covid vaccine worldwide due to 'surplus'
Evening Standard via Yahoo News· 2 months agoAstraZeneca has withdrawn its Covid-19 vaccine from the market due to a “surplus” of new jabs that...